Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

F-Prime Capital Partners Life Sciences Fund Vii Lp investment portfolio

F-Prime Capital Partners Life Sciences Fund Vii Lp has made numerous investments in companies such as Tenpoint Therapeutics Holding, T-Therapeutics, and Proximie within the Healthcare & Life Sciences sector.

vc
Portfolio
7
Team
0

Portfolio (7)

CompanySectorCitySourceLast confirmed on
Aviadobio Ltd
AviadoBio creates gene‑therapy medicines and delivery technologies that target neurodegenerative disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer’s disease, tauopathies and retinal conditions. Its platform combines next‑generation gene‑therapy design with neuroscience expertise and a neuroanatomy‑led approach to deliver treatments to the brain and eye.
Healthcare & Life SciencesLondonConfirmed2025-12-19
Proximie Limited—AltrinchamConfirmed2025-12-04

Sign up to see the full portfolio

+5 more companies

Sign up

Backs Similar Companies

Investors who tend to invest in the same sort of companies.

5 more similar investors hiddenSign up to unlock →

Shareholding changes (6)

F-Prime Capital Partners Life Sciences Fund Vii Lp's positions across portfolio companies
2026
  • 06-24ChangedTenpoint Therapeutics Holding Limited
    • SERIES A 9,959,999 → 0
    • SERIES SEED 1,617,920 → 0
    • SERIES A1 0 → 9,959,999
    • SERIES A2 0 → 1,492,189
    • SERIES B1 0 → 806,011
    • SERIES B2 0 → 4,573,641
    • SERIES B3 0 → 1,392,976
    • SERIES SEED 1 0 → 1,617,920
    • SERIES SEED 2 0 → 242,392
  • 05-23ChangedT-Therapeutics Limited
    • SERIES A 70,539,424 → 0
    • SERIES A-2 0 → 48,397,635
    • SERIES A-1 0 → 62,240,668

Sign up free to see when this investor has bought or sold shares.

+4 more changes

Sign up

Articles (2)